Disease
|
Drug/Important Bio-Agent (IBA)
| 3 | Glutathione (Reduced Glutathione)IBA
01/2024
-
04/2015 |
| 3 | Peptides (Polypeptides)IBA
11/2023
-
05/2018 |
| 2 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
-
11/2022 |
| 1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2024 |
| 1 | gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
12/2023 |
| 1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2023 |
| 1 | Folic Acid (Vitamin M)FDA LinkGeneric
12/2023 |
| 1 | Therapeutic UsesIBA
11/2023 |
| 1 | Hydrogen Sulfide (Sulfide, Hydrogen)IBA
11/2023 |
| 1 | Polytetrafluoroethylene (Teflon)FDA Link
11/2023 |
| 1 | cyclic (arginyl- glycyl- aspartyl- phenylalanyl- lysyl)IBA
11/2023 |
| 1 | DisulfidesIBA
01/2023 |
| 1 | Photosensitizing Agents (Photosensitizers)IBA
11/2022 |
| 1 | Caspase 3 (Caspase-3)IBA
11/2022 |
| 1 | Monoclonal AntibodiesIBA
12/2018 |
| 1 | Fluorescent Dyes (Fluorescent Probes)IBA
05/2018 |
| 1 | Biomarkers (Surrogate Marker)IBA
05/2018 |
| 1 | Coloring Agents (Dyes)IBA
05/2018 |
| 1 | Carbon Nanotubes (Carbon Nanotube)IBA
01/2018 |
| 1 | MicellesIBA
04/2015 |
|
Therapy/Procedure
|